Across TCGA pan-cancer cohorts, CTAGE16P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CTAGE16P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where CTAGE16P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CTAGE16P is over-expressed in tumor, although a few such as KICH and KIRC show the opposite, repressed pattern.

UCEC, KICH, and KIRC are the cancer types where CTAGE16P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CTAGE16P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	+0.090	.012	2	view →
KICH	All	IV	−0.030	.049	1	view →
KIRC	Male	IV	−0.015	.046	1	view →
COAD	Female	II,III,IV	−0.008	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: CTAGE16P RNA expression & survival · all CTAGE16P data types